Literature DB >> 24224439

The protective effect of ellagic acid on lung damage caused by experimental obstructive jaundice model.

M Gul1, I Aliosmanoglu, O Uslukaya, U Firat, H Yüksel, M Gümüs, B V Ulger.   

Abstract

AIM: This study aimed to investigate protective effects of ellagic acid on lungs in an experimental obstructive jaundice model.
METHODS: Four groups were established, each consisting of ten randomly selected rats: Group 1: sham, Group 2: ellagic acid, Group 3: obstructive jaundice, and Group 4: obstructive jaundice + ellagic acid. Ellagic acid was administered orally at a dose of 60 mg/kg/day to group 2 and 4. The animals were sacrificed eight days later. The total oxidative status and the total antioxidant capacity in their lung tissue were determined, and malondialdehyde levels in their blood were measured. Histopathological changes in the lungs were examined.
RESULTS: In the obstructive jaundice group treated with ellagic acid, there was a decrease in malondialdehyde levels and a reduction in the total oxidative status and the oxidative stress index, whereas the total antioxidant capacity increased (p < 0.001). The histopathological examination showed that neutrophil leukocyte infiltration and edema formation decreased and destruction of lung parenchyma disappeared following the treatment with the ellagic acid (p < 0.05).
CONCLUSION: This study shows that ellagic acid has a protective effect against oxidative damage in lung tissue in obstructive jaundice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24224439     DOI: 10.1080/00015458.2013.11680929

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  5 in total

1.  The effects of roflumilast on the pancreas and remote organs in a cerulein-induced experimental acute pancreatitis model in rats.

Authors:  Omer Uslukaya; Ahmet Turkoglu; Umit Can Yazgan; Ibrahim Kaplan; Ibrahim Ibiloglu; Murat Kapan; Metehan Gumus
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

2.  Ellagic acid attenuates beryllium sulphate-induced oxidative stress and histopathological alterations of spleen in rats.

Authors:  Yuandi Lei; Tianyi Jiang; Liqin He; Yanping Liu; Zhanbing Sun; Weihua Deng; Lian Huang; Zhaohui Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

3.  Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities.

Authors:  Abdullah Aslan; Yousif Taha Hussein; Ozlem Gok; Seda Beyaz; Orhan Erman; Serpil Baspinar
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-29       Impact factor: 4.223

4.  Ellagic acid promotes A549 cell apoptosis via regulating the phosphoinositide 3-kinase/protein kinase B pathway.

Authors:  Qiong Liu; Xiaobing Liang; Chengwei Niu; Xuelan Wang
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

5.  Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors.

Authors:  Long Tang; Guoqiang Song; Yajing Wang; Jianchun Jiang; Ziheng Zhuang; Ying Tan; Yan Xia; Xianfeng Huang; Xiaoqing Feng
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.